WO2025243147 - AN ORODISPERSIBLE TABLET OF LAMOTRIGINE AND ITS PROCESS OF PREPARATION
National phase entry is expected:
Publication Number
WO/2025/243147
Publication Date
27.11.2025
International Application No.
PCT/IB2025/055036
International Filing Date
14.05.2025
Title **
[English]
AN ORODISPERSIBLE TABLET OF LAMOTRIGINE AND ITS PROCESS OF PREPARATION
[French]
COMPRIMÉ ORODISPERSIBLE À BASE DE LAMOTRIGINE ET SON PROCÉDÉ DE PRÉPARATION
Applicants **
NOVUMGEN LIMITED
Inventors
PATEL, Kamleshkumar
Priority Data
2407425.4
24.05.2024
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2360 | |
| EPO | Filing, Examination, Granting | 13786 | |
| Japan | Filing, Examination, Granting | 2502 | |
| South Korea | Filing, Examination, Granting | 2739 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
27,327
Contact Us
Abstract[English]
The present invention relates to an orodispersible tablet manufactured by a wet granulation method comprising lamotrigine or pharmaceutically acceptable salts thereof, at least one disintegrant, at least one diluent, at least one binder, at least one glidant, at least one solubilizer, at least one lubricant, and one or more pharmaceutically acceptable excipients. The orodispersible tablet prepared using these excipients exhibits desirable properties such as facilitating disintegration, and dissolution of the drug for oral administration. Further, the present invention also relates to the process for preparing the said solid pharmaceutical composition.[French]
La présente invention concerne un comprimé orodispersible fabriqué par un procédé de granulation humide, contenant de la lamotrigine ou des sels pharmaceutiquement acceptables de celle-ci, au moins un délitant, au moins un diluant, au moins un liant, au moins un agent de glissement, au moins un agent de solubilisation, au moins un lubrifiant et un ou plusieurs excipients pharmaceutiquement acceptables. Le comprimé orodispersible préparé à l'aide desdits excipients présente des propriétés souhaitables telles qu'une facilité de désintégration et de dissolution du médicament pour une administration orale. La présente invention concerne en outre le procédé de préparation de ladite composition pharmaceutique solide.